| scholarly article | Q13442814 |
| P356 | DOI | 10.4088/JCP.V63N1210 |
| P698 | PubMed publication ID | 12523875 |
| P2093 | author name string | Kenneth W Sommerville | |
| Patricia Wozniak | |||
| Alan C Swann | |||
| Richard Weisler | |||
| John M Zajecka | |||
| Gary Sachs | |||
| P433 | issue | 12 | |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 1148-1155 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
| P1476 | title | A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder | |
| P478 | volume | 63 |
| Q35236966 | Acute and long-term treatment of mania. |
| Q35693269 | Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications |
| Q36797200 | Atypical antipsychotics for the treatment of bipolar disorder: more shadows than lights |
| Q21260276 | Atypical antipsychotics in bipolar disorder: systematic review of randomised trials |
| Q57479304 | Bipolar Disorder Mixed Episodes: A Pragmatic Trial of a Public Health Treatment Effectiveness |
| Q52656684 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. |
| Q36544021 | Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder |
| Q22252432 | Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania — A systematic review and meta-analysis |
| Q37100104 | Comparison of mania patients suitable for treatment trials versus clinical treatment |
| Q51007705 | Concomitant use of carbamazepine and olanzapine and the effect on some behavioral functions in rats. |
| Q83215397 | Easing the burden of bipolar disorder: from urgent situations to remission |
| Q24601815 | Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q36568973 | How assess drugs in the treatment of acute bipolar mania? |
| Q33518859 | Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. |
| Q33529314 | Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis |
| Q37997775 | Olanzapine-induced weight gain in patients with bipolar I disorder: a meta-analysis. |
| Q35669961 | Olanzapine-valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group |
| Q35945257 | Olanzapine: a review of its use in the management of bipolar I disorder |
| Q37379028 | Patterns of Psychiatric Outpatient Practice in Taiwan: A Nationwide Survey. |
| Q36361982 | Polytherapy in bipolar disorder |
| Q35613754 | Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? |
| Q24657398 | Review of olanzapine in the management of bipolar disorders |
| Q50779681 | Safety and efficacy of olanzapine monotherapy in treatment-resistant bipolar mania: a 12-week open-label study. |
| Q33988376 | Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review |
| Q46552751 | Spotlight on olanzapine in bipolar I disorder |
| Q47642128 | The Black Book of Psychotropic Dosing and Monitoring |
| Q28066714 | The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm |
| Q34543911 | The geriatric population and psychiatric medication |
| Q36606791 | The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials |
| Q41837093 | Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design |
| Q35673093 | Treatment of acute mania |
| Q36162402 | Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder |
| Q33364302 | Treatment of bipolar disorder: a systematic review of available data and clinical perspectives |
| Q22252976 | Valproate for acute mood episodes in bipolar disorder |
| Q37865505 | Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder. |
Search more.